Measures of reversibility in response to bronchodilators in chronic airflow obstruction

Packe, G E
July 1991
Thorax;Jul1991, Vol. 46 Issue 7, p544
Academic Journal
No abstract available.


Related Articles

  • Diagnosis and treatment of patients with chronic obstructive pulmonary disease in the primary care setting: focus on the role of spirometry and bronchodilator reversibility. Stoloff, Stuart W. // Journal of Family Practice;Apr2011, Vol. 60 Issue 4, pS9 

    The article focuses on the treatment and diagnosis of patients with chronic obstructive pulmonary disease (COPD) in the primary care setting, the clinical relevance of acute bronchodilator reversity, and the role of spirometry in screening patients. It states that the use of spirometry is...

  • Prevalence and treatment of chronic airways obstruction (CAO) in older adults. Renwick, D S; Connolly, M J // Age & Ageing;May94, Vol. 23 Issue 3, British Geriatrics... pP6 

    Assesses lung function and medication use in a random population sample of middle-aged and older adults with chronic airway obstruction (CAO). Completion of a respiratory questionnaire; Measurement of nonspecific bronchial responsiveness (NSBR) by the Newcastle dosimeter method; Measurement of...

  • Steroids in bronchitis.  // British Medical Journal;10/25/1980, Vol. 281 Issue 6248, p1088 

    Investigates the effect of methylprednisolone on chronic obstructive airways disease in Great Britain. Relevance of corticosteroid in the treatment of bronchial asthma; Suppression of the inflammatory response; Reversibility of airways obstruction with bronchodilators.

  • Logistic Regression Model for Prediction of Airway Reversibility Using Peak Expiratory Flow. Shakeri, Javad; Paknejad, Omalbanin; Moghadam, Keivan Gohari; Taherzadeh, Maryam // Tanaffos;2012, Vol. 11 Issue 1, p49 

    Background: Using peak expiratory flow (PEF) as an alternative to spirometry parameters (FEV1 and FVC), for detection of airway reversibility in diseases with airflow limitation is challenging. We developed logistic regression (LR) model to discriminate bronchodilator responsiveness (BDR) and...

  • Phenotype-guided treatment of COPD. Is it the future or the present? Miravitlles, Marc // Hot Topics in Respiratory Medicine;2012, Issue 22, p13 

    The term phenotype as applied to chronic obstructive pulmonary disease (COPD) is defined as "those attributes of the disease that, alone or combined, describe the differences in clinically meaningful parameters between individuals with COPD". Among those described, there are four that are...

  • Bronchodilator reversibility testing in COPD.  // Thorax;Feb2004, Vol. 59 Issue 2, p178 

    A letter to the editor is presented in response to the article "Bronchodilator reversibility testing in chronic obstruction pulmonary disease," by Calverley, Burge, Spencer et al. published in a 2003 issue of the journal.

  • Airway Inflammation and Airflow Limitation in COPD. Diahn-Warng Perng; Kang-Cheng Su; Lung-Yu Liu // Current Respiratory Medicine Reviews;2006, Vol. 2 Issue 4, p419 

    The Global Initiative for Chronic Obstructive Lung Disease guidelines stated that COPD is a disease of airflow limitation that is associated with abnormal inflammatory response. Targeting inflammation and improving airflow is a central goal to treat this disease. Corticosteroids are currently...

  • Overlap Syndrome in Respiratory Medicine: Asthma and Chronic Obstructive Pulmonary Disease. Corlateanu, Alexandru; Pripa, Valeria; Montanari, Gloria; Botnaru, Victor // Journal of Cardio-Thoracic Medicine;2014, Vol. 2 Issue 1, p109 

    Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic diseases in the general population. Both are characterized by similar mechanisms: airway inflammation, airway obstruction, and airway hyperresponsiveness. However, the distinction between the two obstructive...

  • The efficacy and safety of inhaled salmeterol 50 microgram bd in older patients with reversible... Starke, I.D.; Luce, P. // Age & Ageing;Jan1996, Vol. 25 Issue 1, p67 

    Evaluates the efficacy of salmeterol 50 micrograms twice daily in elderly patients with reversible airflow obstruction. Symptoms suffered by the patients; Useof beta2-adrenoreceptor agonists as bronchodilator agents in older patients with reversible airflow obstruction; Potential limitations of...

  • Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Hadcroft, J.; Calverley, P. M. A. // Thorax;Sep2001, Vol. 56 Issue 9, p713 

    Background-Bronchodilator reversibility testing is recommended in all patients with chronic obstructive pulmonary disease (COPD) but does not predict improvements in breathlessness or exercise performance. Two alternative ways of assessing lung mechanics-measurement of end expiratory lung volume...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics